COMMUNIQUÉS West-GlobeNewswire

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
03/06/2026
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line Phase 3 data expected year-end 2026 or early 2027 Novel [...]
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
03/06/2026
SAN DIEGO, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Sapu Nano and Oncotelic Therapeutics (OTCQB:OTLC) today announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) [...]
Earth Science Tech, Inc. (ETST) to Present at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub
03/06/2026
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on a diversified portfolio, today announced that Giorgio R. Saumat, CEO and [...]
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
03/06/2026
RENO, Nev., June 03, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) ("Conexeu" or the "Company") , a biotechnology company advancing tissue regeneration, will ring the Nasdaq Closing Bell on Wednesday, [...]
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation
03/06/2026
Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience group Adds to growing body of real-world evidence with study comparing chemical biomarker data from Nociscan with bone metabolic [...]
iHerb's 618 Big Benefits: Rewarding Users in Hong Kong and Southeast Asia
03/06/2026
IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- iHerb, a globally renowned health and wellness e-commerce platform, which has been established for 29 years, recently launched its 618 Peak Shopping Festival (June 11-20 [...]
Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
03/06/2026
Further clinical efficacy and pharmacology data also to be presented SANDWICH, United Kingdom, June 03, 2026 (GLOBE NEWSWIRE) -- Levicept Ltd, a biotechnology company focused on the development of LEVI-04, a first-in- [...]
Rendre la démocratie attirante de nouveau : le concours « Les animaux de compagnie les plus mignons sur la Colline du Parlement » dévoile ses lauréats 2026
03/06/2026
OTTAWA, Ontario, 03 juin 2026 (GLOBE NEWSWIRE) -- Après des semaines de campagne acharnée, de compétition féroce et plus de 19 000 votes de Canadiens à l’échelle du pays, les lauréats du concours « Les animaux de [...]
Making Democracy Cute Again: Cutest Pets on Parliament Hill Crowns 2026 Winners
03/06/2026
OTTAWA, Ontario, June 03, 2026 (GLOBE NEWSWIRE) -- After weeks of spirited campaigning, fierce competition and over 19,000 votes from Canadians across the country, the winners of the 2026 Cutest Pets on Parliament Hill [...]
Mineralys Therapeutics Announces Repurchase of Royalty Obligations in Tanabe License Agreement and Concurrent Financing
03/06/2026
– Repurchase of lorundrostat royalty obligation in Tanabe license agreement for $200 million upfront and up to $100 million once certain commercial milestones are met – – $500 million committed under senior secured term [...]
Hopstem hNPC01 Cell Injection Earns FDA RMAT Designation for Chronic Stroke Therapy
03/06/2026
HOUSTON, June 03, 2026 (GLOBE NEWSWIRE) -- Hopstem Biotechnology, a clinical-stage biotech specializing in iPSC-derived cell therapeutics for neurological diseases, has secured the first Regenerative Medicine Advanced [...]
Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
03/06/2026
Nipocalimab – the first neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus erythematosus – is designed to target and reduce pathogenic immunoglobulin G (IgG) autoantibodies associated with this disease [...]
Communiqué de presse : Sanofi fédère l'écosystème de santé pour accélérer le diagnostic des maladies rares en France : Biogen rejoint accelRare
03/06/2026
Sanofi fédère l’écosystème de santé pour accélérer le diagnostic des maladies rares en France : Biogen rejoint accelRare Paris, 3 juin 2026 - Sanofi annonce aujourd’hui l’arrivée de Biogen au sein d’ accelRare , outil [...]
Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc
03/06/2026
Communiqué de presse Nicox : Convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 24 juin 2026 et désignation d’un mandataire ad hoc 3 juin 2026 – publication à 7H30 Sophia Antipolis, France Nicox SA ( [...]
JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)
03/06/2026
Favorable safety and tolerability profile, with rapid onset of clinical activity and therapeutic effects observed in patients with LAD Data support the start of a Phase 1b clinical trial in rheumatoid arthritis, [...]
Chiesi Global Rare Diseases to Launch the Second Edition of Find For Rare at 2026 ERA Congress to Advance Research in Lysosomal Storage Disorders
03/06/2026
-- At ERA 2026, Chiesi will contribute to advancing the scientific understanding of Fabry disease and nephropathic cystinosis through real-world experience and clinical outcomes, supporting the needs of the community of [...]
Wegovy® pill launches in the UAE as Novo Nordisk expands global access to obesity care
03/06/2026
Novo Nordisk launches Wegovy ® pill in the United Arab Emirates today Wegovy ® pill is indicated to reduce excess body weight and maintain weight reduction long-term Wegovy ® pill, providing a mean weight loss of 17%, [...]
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
03/06/2026
ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+ data in Sjogren’s disease indicate maintenance of response following switch to biweekly [...]
Inteleos and Medvarsity Partner to Expand Global POCUS Education Access
03/06/2026
New collaboration delivers the POCUS Fundamentals Certificate to clinicians worldwide, creating a structured entry point for point-of-care ultrasound training. ROCKVILLE, Md. and HYDERABAD, India, June 03, 2026 (GLOBE [...]

Pages